Probable new species of Desulfovibrio isolated from a pyogenic liver abscess

Tee, Wee; Dyall‐Smith, Mike; Woods, Walter H.; Eisen, Damon P.

doi:10.1128/jcm.34.7.1760-1764.1996

Cited by 74 publications

(58 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, it would be interesting to follow the patients with IBD over a longer period of time to determine if the activity of the disease has a consequence on the population of SRB. D. desulfuricans is commonly isolated from the environment, and has also been considered as the most prevalent species of Desulfovibrio in humans [9,11] until the recent description of D. fair¢eldensis [16]. Thus, one may be surprised about the very low occurrence of D. desulfuricans in our population.…”

Section: Discussionmentioning

confidence: 89%

“…The sensitivity of the PCR was evaluated with dilutions of quanti¢ed bacterial strain suspensions. The speci¢city of the PCR was checked with negative controls including type strains (Bilophila wadsworthia ATCC 49260 T [16] was performed to check the absence of inhibition of the PCRs by contaminants.…”

Section: Srb Identi¢cation By Multiplex Pcrmentioning

confidence: 99%

“…They have been associated with the clinical severity of human periodontitis [12], and isolated from profound abscesses (abdominal or brain), blood or urine [13^16]. In these settings, most strains have been identi¢ed as Desulfovibrio fair¢eldensis, a recently proposed new species [16], by 16S ribosomal RNA gene (16S rDNA) sequencing. Desulfovibrio desulfuricans, the type species of the genus Desulfovibrio, has also been isolated from human specimens [14].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases

Loubinoux

2002

FEMS Microbiology Ecology

View full text Add to dashboard Cite

We have searched for sulfate-reducing bacteria in the feces of 41 healthy individuals and 110 patients from a Hepato-Gastro-Enterology Unit using a specific liquid medium (Test-kit Labe 'ge 0 , Compagnie Franc°aise de Ge ¤othermie, Orle ¤ans, France). The 110 patients were separated in 22 patients presenting with inflammatory bowel diseases and 88 patients hospitalized for other lower (n = 30) or upper (n = 58) digestive tract diseases. Sulfate-reducing bacteria were isolated from 10 healthy individuals (24%), 15 patients presenting with inflammatory bowel diseases (68%), and 33 patients with other symptoms (37%). A multiplex PCR was devised for the identification of Desulfovibrio piger (formerly Desulfomonas pigra), Desulfovibrio fairfieldensis and Desulfovibrio desulfuricans, and applied to the above isolates. The strains of sulfate-reducing bacteria consisted of D. piger (39 isolates), D. fairfieldensis (19 isolates) and D. desulfuricans (one isolate). The prevalence of D. piger was significantly higher in inflammatory bowel disease patients (55%) as compared to healthy individuals (12%) or patients with other symptoms (25%) (P 6 0.05). ß

show abstract

Section: Discussionmentioning

confidence: 89%

Section: Srb Identi¢cation By Multiplex Pcrmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases

Loubinoux

2002

FEMS Microbiology Ecology

View full text Add to dashboard Cite

show abstract

“…The isolates were also tested for growth on bile-aesculin agar and in Todd-Hewitt broth containing NaCl 6.5% w ⁄ v. Biochemical traits were determined using the Rapid ID32 STREP identification system (bioMérieux, Marcy l'Etoile, France). When the isolate could not be assigned to an individual species because of atypical results, a 1500-bp fragment of the 16S rRNA gene was amplified with primers 27f and 1525r, according to the method of Tee et al [25], and 16S rRNA gene sequence analysis was performed [26].…”

Section: P a T I E N T S A N D M E T H O D Smentioning

confidence: 99%

Characteristics and regional variations of group D streptococcal endocarditis in France

Giannitsioti

Chirouze

Bouvet

et al. 2007

Clinical Microbiology and Infection

View full text Add to dashboard Cite

The proportion of infective endocarditis (IE) caused by group D streptococci (GDS; formerly Streptococcus bovis) increased markedly in France, to account for 25% of all cases of IE by 1999. In an attempt to explain this phenomenon, a comparative analysis of GDS and oral streptococci (OS) causing IE was performed. This study was based on data collected from a large cross-sectional population-based survey that was conducted in 1999. In total, 559 cases of definite IE were recorded, of which 142 involved GDS and 79 involved OS. Patients with GDS IE were older (62.7 vs. 56.6 years, p 0.01) and had a history of valve disease less frequently than did patients with OS IE (33.8% vs. 67.1%, p <0.0001). At-risk procedures for IE were performed less frequently in patients with GDS than in patients with OS (14.8% vs. 24.1%, p 0.08), but co-morbidities were more frequent in the GDS group (59.9% vs. 32.9%, p 0.0001). Diabetes, colon diseases and cirrhosis were also more frequent in the GDS group (p 0.006, p <0.0001 and p 0.08, respectively). Rural residents accounted for 31.0% of the GDS group, but for only 15.2% of the OS group (p 0.001). Likewise, the proportion of GDS IE was higher in regions with mixed (urban and rural) populations (Franche-Comté 81.8%, Marne 68.7%, Lorraine 70.3% and Rhône-Alpes 65.3%) than in exclusively urban regions (Paris and Ile de France 58.0%). Further investigations are required to elucidate the link in France between the incidence of GDS IE, rural residency and nutritional factors.

show abstract

“…Some bacteria belonging to the genus Desulfovibrio are known to cause several infectious diseases in humans: Desulfovibrio desulfuricans, Desulfovibrio piger, Desulfovibrio vulgaris and Desulfovibrio fairfieldensis (Tee et al 1996;Loubinoux et al 2000;Goldstein et al 2003;Warren et al 2005). Especially, Des.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of a biofilm formation by Desulfovibrio fairfieldensis on titanium implants

Jorand

Debuy

Kamagate

et al. 2015

Lett Appl Microbiol

View full text Add to dashboard Cite

Desulfovibrio fairfieldensis is one of the most relevant sulphate-reducing bacteria of the human oral cavity suspected to be involved in peri-implantitis and implant corrosion. This study demonstrates for the first time that Des. fairfieldensis is able to initiate the formation of a biofilm-like structure on the microstructured titanium coupons used in dental implants and that it improves its resistance to antibiotic treatment. It gives new insight to understand the capacity of this opportunistic pathogen to colonize implant surfaces and to resist to biocide treatments.

show abstract

Probable new species of Desulfovibrio isolated from a pyogenic liver abscess

Cited by 74 publications

References 27 publications

Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases

Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases

Characteristics and regional variations of group D streptococcal endocarditis in France

Evaluation of a biofilm formation by Desulfovibrio fairfieldensis on titanium implants

Contact Info

Product

Resources

About